|
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
|
1R01CA231291-01
|
$533,211
|
|
WELLSTEIN, ANTON
|
GEORGETOWN UNIVERSITY
|
|
(PQ1) Cellular senescence as an initiating event in malignant transformation
|
5R21CA206013-02
|
$169,500
|
$169,500
|
DAVID, GREGORY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(PQ1) The role of cell-to-cell variation in the penetrance of heritable mutant RAS hypodermal neoplasias
|
1R01CA219460-01A1
|
$397,573
|
|
MENDENHALL, ALEXANDER
|
UNIVERSITY OF WASHINGTON
|
|
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
|
5R01CA208644-03
|
$377,438
|
$377,438
|
CRITTENDEN, MARKA
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
(PQ4) Quantitative and multiplexed analysis of gene function in cancer in vivo
|
1R01CA231253-01
|
$471,700
|
|
WINSLOW, MONTE
|
STANFORD UNIVERSITY
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
3R01CA194461-04S1
|
$7,505
|
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ5) Contribution of mitochondrial pathways to metabolic heterogeneity in molecular subtypes of Diffuse Large B Cell Lymphoma
|
1R01CA219850-01A1
|
$558,022
|
|
DANIAL, NIKA
|
DANA-FARBER CANCER INST
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
3R01CA208642-03S1
|
$71,387
|
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
3R01CA208642-03S2
|
$83,925
|
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Informing anal neoplasia differences/similarities in HIV-serodiscordant individuals
|
3R21CA216830-02S1
|
$68,478
|
|
SHIRAMIZU, BRUCE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
|
1R01CA231295-01
|
$481,288
|
|
OSMAN, IMAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(PQ9) Developing EZH2 Degraders for Treating Triple-Negative Breast Cancer
|
1R01CA230854-01
|
$249,841
|
|
JIN, JIAN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
3P20CA192994-04S1
|
$62,420
|
$36,828
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
3P20CA192994-04S2
|
$48,381
|
$28,545
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
5P20CA192994-04
|
$277,311
|
$163,613
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
|
1U54CA233396-01
|
$1,008,781
|
$605,269
|
REAMS, ROMONIA
|
FLORIDA AGRICULTURAL AND MECHANICAL UNIV
|
|
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
3P20CA202925-03S1
|
$104,165
|
|
PATIERNO, STEVEN
|
DUKE UNIVERSITY
|
|
2/2 Partnership to Study Racial/Ethnic Differences in GI Cancer Biology
|
5P20CA192996-04
|
$154,589
|
$100,483
|
MCCOMBIE, WILLIAM
|
COLD SPRING HARBOR LABORATORY
|
|
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132384-09
|
$1,192,031
|
$429,131
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
|
1U54CA233444-01
|
$1,054,795
|
$348,082
|
ODEDINA, FOLAKEMI
|
UNIVERSITY OF FLORIDA
|
|
2015 Radiation Epidemiology Course
|
ZIA CP010131 10596
|
$30,751
|
|
Berrington, Amy
|
DCEG (NCI)
|
|
2018 Biomineralization Gordon Research Conference & Gordon Research Seminar
|
1R13DE028191-01
|
$2,000
|
|
JOESTER, DERK
|
GORDON RESEARCH CONFERENCES
|
|
2018 Cell Death Gordon Research Conference and Gordon Research Seminar
|
1R13CA232392-01
|
$4,000
|
|
CHAN, FRANCIS
|
GORDON RESEARCH CONFERENCES
|
|
2018 Chromatin Structure & Function Gordon Research Conference & Gordon Research Seminar
|
1R13CA232441-01
|
$8,000
|
|
LUGER, KAROLIN
|
GORDON RESEARCH CONFERENCES
|
|
2018 In Vivo Magnetic Resonance Gordon Research Conference & Gordon Research Seminar
|
1R13EB026933-01
|
$5,000
|
|
SODICKSON, DANIEL
|
GORDON RESEARCH CONFERENCES
|
|
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
|
1U54CA233465-01
|
$1,141,251
|
$216,838
|
CARPTEN, JOHN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
30th International Workshop on Retroviral Pathogenesis
|
1R13CA232205-01
|
$4,000
|
|
GREEN, PATRICK
|
OHIO STATE UNIVERSITY
|
|
3D biomimetic image-based stromal models of pancreatic cancer for drug screening
|
1R21CA224280-01A1
|
$213,829
|
$213,829
|
CAMPAGNOLA, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
8th Great Lakes Nuclear Receptors Conference (GLNRC)
|
1R13CA236225-01
|
$5,000
|
|
DEHM, SCOTT
|
UNIVERSITY OF MINNESOTA
|
|
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer
|
1R37CA222294-01A1
|
$366,000
|
|
ABAZEED, MOHAMED
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
A Clinical Validation Center for Early Detection of Pancreatic Cancer
|
5U01CA200468-03
|
$760,296
|
$760,296
|
MAITRA, ANIRBAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
A cohort mortality study with a nested case-control study of lung cancer and dies
|
ZIA CP010120 02091
|
$582,330
|
|
Silverman, Debra
|
DCEG (NCI)
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120 02060
|
$79,723
|
|
Rothman, Nat
|
DCEG (NCI)
|
|
A combined single cell gene expression and enzyme activity assay to study chemotherapy resistance in pancreatic ductal adenocarcinoma
|
1F31CA228223-01
|
$35,681
|
$35,681
|
PETERSEN, BRAE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer
|
1U01CA233363-01
|
$587,514
|
|
COTE, RICHARD
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
A differentiation-based mechanism limiting pancreatic tumor initiation
|
5F30CA192819-04
|
$49,524
|
$49,524
|
KRAH, NATHAN
|
UNIVERSITY OF UTAH
|
|
A Federated Galaxy for user-friendly large-scale cancer genomics research
|
1U24CA231877-01
|
$823,902
|
|
GOECKS, JEREMY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5U01CA164974-08
|
$3,131,894
|
$313,189
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Galaxy?based multi?omic informatics hub for cancer researchers
|
3U24CA199347-03S1
|
$25,582
|
|
GRIFFIN, TIMOTHY
|
UNIVERSITY OF MINNESOTA
|
|
A high-throughput platform for neo-antigen based cancer immunotherapy
|
1R43CA233120-01
|
$299,917
|
|
XIAO, JUN
|
IMMUDX, LLC
|
|
A HTS Approach to Discover Guanine Nucleotide-Competitive Inhibitors of Oncogenic KRAS
|
1R01CA223495-01A1
|
$454,077
|
$149,845
|
ROSSMAN, KENT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$154,883
|
|
Kelly Siebenlist, Kathleen
|
CCR (NCI)
|
|
A multi-center international hospital-based case-control study of lymphoma in Asi
|
ZIA CP010136 10512
|
$1,398,817
|
|
Lan, Qing
|
DCEG (NCI)
|
|
A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer
|
1K08CA234335-01
|
$196,414
|
|
THOMPSON, JEFFREY
|
UNIVERSITY OF PENNSYLVANIA
|
|
A New Target for Chromatin Remodeler Defects in Cancer
|
1R35CA231993-01
|
$594,375
|
|
WALKER, CHERYL
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Novel Clinically Relevant Tumor Suppressor in Human Breast Cancer
|
1R03CA223709-01A1
|
$77,255
|
|
SPINELLA, MICHAEL
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
A novel miR-198 replacement therapy for pancreatic cancer
|
5R01CA183984-04
|
$473,915
|
$473,915
|
YAO, QIZHI
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel molecular cross-talk driving pancreatic cancer progression
|
1R01CA224306-01
|
$346,556
|
$346,556
|
SINGH, AJAY
|
UNIVERSITY OF SOUTH ALABAMA
|
|
A novel protein engineering tool for rapid manufacturing of designer nucleosomes
|
2R44CA214076-02
|
$999,997
|
|
KEOGH, MICHAEL-CHRISTOPHER
|
EPICYPHER, INC.
|
|
A Paradigm Shift in Chronic Lymphocytic Leukemia: Defining the Role of Hematopoietic Stem Cells in Leukemogenesis
|
1F30CA225070-01A1
|
$38,725
|
|
HU, EILEEN
|
OHIO STATE UNIVERSITY
|
Total relevant funding to Pancreas for this search: $188,242,669
|